Oral Sulopenem Etzadroxil With Probenecid Versus Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infections (uUTI) in Adult Women

Trial Profile

Oral Sulopenem Etzadroxil With Probenecid Versus Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infections (uUTI) in Adult Women

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 30 Nov 2017

At a glance

  • Drugs Sulopenem (Primary)
  • Indications Urinary tract infections
  • Focus Therapeutic Use
  • Sponsors Iterum Therapeutics
  • Most Recent Events

    • 25 Nov 2017 Status changed from planning to not yet recruiting.
    • 25 Jul 2017 According to an Iterum Therapeutics media release, company anticipates initiation of this clinical trial in 2018.
    • 11 Jan 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top